scholarly article | Q13442814 |
P50 | author | Mel Krajden | Q6810759 |
James A Dickinson | Q42422634 | ||
Catharine Chambers | Q57259188 | ||
Yan Li | Q69032212 | ||
Nathalie Bastien | Q69032280 | ||
Gaston De Serres | Q86870133 | ||
Jonathan B Gubbay | Q87716515 | ||
Steven J Drews | Q90185362 | ||
Alireza Eshaghi | Q94927841 | ||
Christine Martineau | Q107855435 | ||
Danuta M. Skowronski | Q111259505 | ||
Suzana Sabaiduc | Q114718265 | ||
Anne-Luise Winter | Q114718267 | ||
Trijntje L Kwindt | Q114718277 | ||
P2860 | cites work | Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies | Q38803189 |
Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15. | Q39961932 | ||
Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results | Q40357312 | ||
Influenza activity - United States, 2014-15 season and composition of the 2015-16 influenza vaccine | Q40870040 | ||
Mutations acquired during cell culture isolation may affect antigenic characterisation of influenza A(H3N2) clade 3C.2a viruses | Q40935953 | ||
Interim estimates of 2014/15 influenza vaccine effectiveness in preventing laboratory-confirmed influenza-related hospitalisation from the Serious Outcomes Surveillance Network of the Canadian Immunization Research Network, January 2015. | Q41442929 | ||
Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015. | Q41474318 | ||
Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015. | Q41543622 | ||
Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution | Q42253862 | ||
Recommended composition of influenza virus vaccines for use in the 2014-2015 northern hemisphere influenza season | Q56767236 | ||
SWISS-MODEL: An automated protein homology-modeling server | Q24672647 | ||
Randomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease risk | Q27330166 | ||
FastTree 2--approximately maximum-likelihood trees for large alignments | Q28748616 | ||
Mortality associated with influenza and respiratory syncytial virus in the United States | Q29615578 | ||
Predicting the evolution of human influenza A. | Q30011145 | ||
Estimating influenza deaths in Canada, 1992-2009. | Q30356489 | ||
Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection. | Q30360290 | ||
Glycosylation Analysis of Engineered H3N2 Influenza A Virus Hemagglutinins with Sequentially Added Historically Relevant Glycosylation Sites. | Q30377052 | ||
Clinical and epidemiologic characteristics of an outbreak of novel H1N1 (swine origin) influenza A virus among United States military beneficiaries | Q30382515 | ||
Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada | Q30388012 | ||
Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong | Q30396064 | ||
Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children | Q30408006 | ||
Association between seasonal influenza vaccination in 2008-2009 and pandemic influenza A (H1N1) 2009 infection among school students from Kobe, Japan, April-June 2009. | Q30409721 | ||
Immunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza viruses | Q30419865 | ||
Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates | Q33554684 | ||
Serologic assays for influenza surveillance, diagnosis and vaccine evaluation | Q34194336 | ||
Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons | Q34393525 | ||
Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review | Q34778408 | ||
Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses | Q35130915 | ||
Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type | Q35531934 | ||
Mid-Season Estimates of Influenza Vaccine Effectiveness against Influenza A(H3N2) Hospitalization in the Elderly in Quebec, Canada, January 2015 | Q35705382 | ||
Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility | Q35715694 | ||
Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season | Q35805949 | ||
Variable efficacy of repeated annual influenza vaccination | Q36705674 | ||
Influenza vaccine effectiveness in the community and the household | Q36956943 | ||
Assessment of influenza vaccine effectiveness in a sentinel surveillance network 2010-13, United States | Q36957563 | ||
Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines | Q37208841 | ||
Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11. | Q37568436 | ||
Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season | Q38415770 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | influenza vaccine | Q383260 |
P304 | page(s) | 21-32 | |
P577 | publication date | 2016-03-29 | |
P1433 | published in | Clinical Infectious Diseases | Q5133764 |
P1476 | title | A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season | |
P478 | volume | 63 |
Q38410159 | 2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type |
Q40087098 | 2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project. |
Q56991712 | A Multiplex Asymmetric Reverse Transcription-PCR Assay Combined With an Electrochemical DNA Sensor for Simultaneously Detecting and Subtyping Influenza A Viruses |
Q93089924 | A framework for research on vaccine effectiveness |
Q99207892 | Adjuvanticity of Processed Aloe vera gel for Influenza Vaccination in Mice |
Q41932798 | Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010-2011 to 2015-2016, Canada |
Q49713969 | An updated influenza A(H3N2) vaccine generates limited antibody responses to previously encountered antigens in children |
Q37591325 | Antibody Responses to Trivalent Inactivated Influenza Vaccine in Health Care Personnel Previously Vaccinated and Vaccinated for The First Time |
Q90299458 | Assessment of population susceptibility to upcoming seasonal influenza epidemic strain using interepidemic emerging influenza virus strains |
Q50065275 | Beyond Antigenic Match: Moving Toward Greater Understanding of Influenza Vaccine Effectiveness |
Q47678684 | Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons |
Q92915035 | Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort |
Q64054477 | Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: possible cohort effect following the 2009 influenza pandemic |
Q90131599 | Clinical trial to assess immunogenicity of high-dose, adjuvanted, and recombinant influenza vaccines against cell-grown A(H3N2) viruses in adults 65 to 74 years, 2017-2018 |
Q90621783 | Comparison of human H3N2 antibody responses elicited by egg-based, cell-based, and recombinant protein-based influenza vaccines during the 2017-2018 season |
Q57471354 | Comprehensive analysis of N-glycans in IgG purified from ferrets with or without influenza A virus infection |
Q47150783 | Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. |
Q39215322 | Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Post-vaccination Sera |
Q93367325 | Diminished B-Cell Response After Repeat Influenza Vaccination |
Q53283393 | Does consecutive influenza vaccination reduce protection against influenza: A systematic review and meta-analysis. |
Q64130248 | Effect of Previous-Season Influenza Vaccination on Serologic Response in Children During 3 Seasons, 2013-2014 Through 2015-2016 |
Q30391150 | Effect of Statin Use on Influenza Vaccine Effectiveness |
Q52689551 | Effectiveness of influenza vaccine in preventing medically-attended influenza virus infection in primary care, Israel, influenza seasons 2014/15 and 2015/16. |
Q41932605 | Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies |
Q38378102 | Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season |
Q31161295 | Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies |
Q98578103 | Effects of Prior Influenza Exposure on Immunogenicity of Influenza Vaccine |
Q40670577 | Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015. |
Q58722425 | Estimating Vaccine-Driven Selection in Seasonal Influenza |
Q61848787 | Estimating influenza vaccine effectiveness using data routinely available in electronic primary care records |
Q47363883 | Estimating vaccine effectiveness against laboratory-confirmed influenza among children and adolescents in Lower Saxony and Saxony-Anhalt, 2012-2016. |
Q37681302 | Evaluating the effectiveness, impact and safety of live attenuated and seasonal inactivated influenza vaccination: protocol for the Seasonal Influenza Vaccination Effectiveness II (SIVE II) study. |
Q52805071 | Exploring the effect of previous inactivated influenza vaccination on seasonal influenza vaccine effectiveness against medically-attended influenza: results of the European I-MOVE multicentre test-negative case-control study, 2011/12-2016/17. |
Q57022286 | Frequent Genetic Mismatch between Vaccine Strains and Circulating Seasonal Influenza Viruses, Hong Kong, China, 1996-2012 |
Q59349308 | Immune History and Influenza Vaccine Effectiveness |
Q39088963 | Immune history and influenza virus susceptibility |
Q59351989 | Immunizing the Immune: Can We Overcome Influenza's Most Formidable Challenge? |
Q47564122 | Impact of seasonal influenza vaccination in the presence of vaccine interference |
Q52315590 | Imprinting of Repeated Influenza A/H3 Exposures on Antibody Quantity and Antibody Quality: Implications on Seasonal Vaccine Strain Selection and Vaccine Performance. |
Q90858175 | Inactivated influenza vaccine effectiveness and an analysis of repeated vaccination for children during the 2016/17 season |
Q49820109 | Increase in Hospital Admissions for Severe Influenza A/B among Travelers on Cruise Ships to Alaska, 2015. |
Q47549841 | Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States |
Q30397977 | Influenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement |
Q90246622 | Influenza Vaccine Effectiveness in Preventing Hospitalizations in Older Patients With Chronic Obstructive Pulmonary Disease |
Q40089214 | Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season |
Q90255566 | Influenza outbreaks in Ontario hospitals, 2012-2016 |
Q40261504 | Influenza vaccination responses: Evaluating impact of repeat vaccination among health care workers |
Q40068128 | Influenza vaccine effectiveness against medically attended influenza illness in Beijing, China, 2014/15 season |
Q54277492 | Influenza vaccine effectiveness in older adults compared with younger adults over five seasons. |
Q55339340 | Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17. |
Q52651633 | Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Seriou |
Q59349704 | Influenza-Associated Parotitis During the 2014-2015 Influenza Season in the United States |
Q37652088 | Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017. |
Q47413448 | Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season. |
Q37708550 | Mid-season real-time estimates of seasonal influenza vaccine effectiveness in persons 65 years and older in register-based surveillance, Stockholm County, Sweden, and Finland, January 2017 |
Q40280573 | Moving Toward Improved Influenza Vaccines |
Q39422605 | Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan |
Q91898584 | Nephrotic syndrome following four-component meningococcal B vaccination: Epidemiologic investigation of a surveillance signal |
Q41930762 | Perspectives from the society for pediatric research (SPR): Decreased effectiveness of the live attenuated influenza vaccine (LAIV). |
Q53767227 | Pooling and the Potential Dilution of Repeat Influenza Vaccination Effects. |
Q90435489 | Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract Infections |
Q92526352 | Prior influenza vaccination effects on vaccine effectiveness: a point of consideration for health care workers |
Q40152643 | Prior-Season Vaccination and Risk of Influenza During the 2014-2015 Season in the United States |
Q37422072 | Real-time real-world analysis of seasonal influenza vaccine effectiveness: method development and assessment of a population-based cohort in Stockholm County, Sweden, seasons 2011/12 to 2014/15. |
Q64130675 | Reduction of influenza A(H3N2)-associated symptoms by influenza vaccination in school aged-children during the 2014-2015 winter season dominated by mismatched H3N2 viruses |
Q40280348 | Repeated Vaccination Does Not Appear to Impact Upon Influenza Vaccine Effectiveness Against Hospitalization With Confirmed Influenza |
Q39340731 | Repeated annual influenza vaccination and vaccine effectiveness: review of evidence |
Q38678530 | Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza. |
Q40146222 | Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations - Latin America, 2013. |
Q30151372 | Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015. |
Q57100141 | Should Sex Be Considered an Effect Modifier in the Evaluation of Influenza Vaccine Effectiveness? |
Q40248207 | The Doctrine of Original Antigenic Sin: Separating Good From Evil |
Q47700569 | The Effectiveness of Trivalent Inactivated Influenza Vaccine in Children with Acute Leukemia |
Q41919202 | The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014-2015 Influenza Vaccine |
Q90745138 | The Role of Clinical Virology Laboratory and the Clinical Virology Laboratorian in Ensuring Effective Surveillance for Influenza and Other Respiratory Viruses: Points to Consider and Pitfalls to Avoid |
Q90692852 | The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology |
Q47136504 | The effectiveness of influenza vaccination in preventing hospitalisations of elderly individuals in two influenza seasons: a multicentre case-control study, Spain, 2013/14 and 2014/15. |
Q50453718 | The evolution of seasonal influenza viruses |
Q96813808 | The impact of candidate influenza virus and egg-based manufacture on vaccine effectiveness: Literature review and expert consensus |
Q38639994 | The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis |
Q60912426 | The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis |
Q94568355 | Use of self-reported vaccination status can bias vaccine effectiveness estimates from test-negative studies |
Q90423467 | Using population-wide administrative and laboratory data to estimate type- and subtype-specific influenza vaccine effectiveness: a surveillance protocol |
Search more.